![Lyn Baranowski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lyn Baranowski
Directeur Général chez
AVALYN PHARMA INC.
Fortune : - $ au 31/08/2026
Profil
Ms. Lyn Baranowski is a Chief Executive Officer & Director at Avalyn Pharma, Inc. She is on the Board of Directors at Avalyn Pharma, Inc. and Rani Therapeutics LLC.
Ms. Baranowski was previously employed as an Independent Director by Rani Therapeutics Holdings, Inc., a Senior VP-Corporate Development & Strategy by Melinta Subsidiary Corp., a Senior VP-Corporate Development & Strategy by Melinta Therapeutics, Inc., a Chief Operating Officer by Altavant Sciences, Inc., a Vice President-Commercial Development by Pearl Therapeutics, Inc., and a Vice President by Vatera Healthcare Partners.
She also served on the board at Novartis Pharmaceuticals Corp.
She received her undergraduate degree from American University and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVALYN PHARMA INC -.--% | 30/04/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Lyn Baranowski
| Sociétés | Poste | Début |
|---|---|---|
| AVALYN PHARMA INC. | Directeur Général | 14/10/2022 |
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Directeur/Membre du Conseil | - |
Anciens postes connus de Lyn Baranowski
| Sociétés | Poste | Fin |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Directeur/Membre du Conseil | 02/05/2023 |
| MELINTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2018 |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops life-saving medicines for patients with rare respiratory diseases | Directeur des opérations | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Directeur/Membre du Conseil | - |
Vatera Healthcare Partners
 Vatera Healthcare Partners Investment ManagersFinance Vatera Healthcare invests in companies located in the United States. The firm targets companies operating across wide variety of biopharmaceutical sector. It provides financing for seed, early and later stage capital requirements. | Corporate Officer/Principal | - |
Formation de Lyn Baranowski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
American University
 American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Health Technology |
Vatera Healthcare Partners
Vatera Healthcare Partners Investment ManagersFinance Vatera Healthcare invests in companies located in the United States. The firm targets companies operating across wide variety of biopharmaceutical sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
Altavant Sciences, Inc.
Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops life-saving medicines for patients with rare respiratory diseases | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
